Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share financials
$14.39+0.56%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $121.4M | $114.6M | $108.7M | $97.7M | $90.6M | $75.7M | $60.8M | $48.6M | $37.3M | $25.2M |
| Gross profit | $97.7M | $91.7M | $88.0M | $97.7M | $75.4M | $75.7M | $60.8M | $48.6M | $37.3M | $25.2M |
| Gross margin | 80.5% | 80.1% | 80.9% | 100.0% | 83.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $29.1M | $29.9M | $20.9M | $33.9M | $32.9M | $27.9M | $18.7M | $13.4M | $6.9M | $3.9M |
| Net income | $2.1M | -$6.0M | $5.1M | $19.2M | $20.2M | $17.2M | $7.0M | $3.3M | $2.8M | $2.7M |
| Net margin | 1.7% | −5.2% | 4.7% | 19.6% | 22.3% | 22.8% | 11.4% | 6.9% | 7.5% | 10.8% |
| Diluted EPS | $0.08 | $-0.23 | $0.20 | $0.81 | $0.87 | $0.80 | $0.37 | $0.19 | $0.19 | $0.24 |
| EBITDA | $74.0M | $73.6M | $61.4M | $67.1M | $64.1M | $53.4M | $41.4M | $33.6M | $25.1M | $17.3M |
| Operating cash flow | $56.4M | $58.9M | $61.4M | $53.6M | $46.0M | $48.4M | $32.4M | $22.2M | $8.4M | $14.9M |
| Free cash flow | -$28.7M | -$38.1M | -$56.5M | -$53.5M | -$49.3M | -$85.4M | -$122.0M | -$27.5M | -$126.3M | $13.3M |
| Diluted shares | 26.9M | 26.5M | 25.2M | 23.6M | 23.3M | 21.6M | 18.7M | 17.7M | 14.8M | 11.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.3M | $4.4M | $3.5M | $11.2M | $2.4M | $2.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $532.2M | $486.0M | $403.3M | $353.0M | $265.6M | $212.4M |
| Total assets | $990.8M | $992.6M | $945.4M | $876.4M | $754.2M | $668.4M |
| Total liabilities | $561.4M | $516.6M | $432.2M | $379.6M | $292.1M | $238.5M |
| Shareholders' equity | $429.4M | $476.0M | $513.3M | $496.8M | $462.1M | $429.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology